MedPath

A study to evaluate the taste and acceptability of Zinc tablets in children with diarrhoea

Phase 3
Suspended
Conditions
Health Condition 1: null- Acute childhood diarrhoea
Registration Number
CTRI/2009/091/000592
Lead Sponsor
Panacea Biotec Limited
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Suspended
Sex
Not specified
Target Recruitment
320
Inclusion Criteria

Children aged less than or equal 3 months to less than 59 months who present in the hospital with more than three unformed stools in 24 hours and diarrheal duration of <7 days will be eligible after written informed consent from their parent/legally acceptable representative (LAR)

Exclusion Criteria

-Children with intractable vomiting, pre-renal or renal failure, respiratory distress, altered sensorium or any such co-morbid condition that precludes the use of oral rehydration solution (ORS) will be excluded from the trial
-Child enrolled earlier in this or any other clinical trial in last one month
-Children with severe malnutrition (kwashiorkar and marasmus)
-Children with clinically significant co-morbid condition that in the opinion of the investigator could affect the safety of the subject and efficacy outcome of the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
-To evaluate the acceptability which will be evaluated by the parent/LAR report of his/her child&#039;s behavior when given the medication.Timepoint: At the end of study;-To evaluate the adherence: this will be evaluated in relation to the dose given, frequency of daily administration, duration of treatment and preparation.Timepoint: At the end of study
Secondary Outcome Measures
NameTimeMethod
oneTimepoint: None
© Copyright 2025. All Rights Reserved by MedPath